{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:04:11Z","timestamp":1777561451624,"version":"3.51.4"},"reference-count":46,"publisher":"American Physiological Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Physiology-Endocrinology and Metabolism"],"published-print":{"date-parts":[[2006,11]]},"abstract":"<jats:p>Kisspeptin is a 54-amino acid peptide, encoded by the anti-metastasis gene KiSS-1, that activates G protein-coupled receptor 54 (GPR54). The kisspeptin-GPR54 system is critical to normal reproductive development. KiSS-1 gene expression is increased in the human placenta in normal and molar pregnancies. Circulating kisspeptin is dramatically increased in normal pregnancy, but levels in GTN have not previously been reported. The present study was designed to determine whether plasma kisspeptin levels are altered in patients with malignant GTN. Thirty-nine blood samples were taken from 11 patients with malignant GTN at presentation during and after chemotherapy. Blood was also sampled from nonpregnant and pregnant volunteers. Plasma kisspeptin IR and hCG concentrations were measured. Plasma kisspeptin IR concentration in nonpregnant ( n = 16) females was &lt;2 pmol\/l. Plasma kisspeptin IR in females was 803 \u00b1 125 pmol\/l in the first trimester of pregnancy ( n = 13), 2,483 \u00b1 302 pmol\/l in the third trimester of pregnancy ( n = 7), and &lt;2 pmol\/l on day 15 postpartum ( n = 7). Plasma kisspeptin IR and hCG concentrations in patients with malignant GTN were elevated at presentation and fell during and after treatment with chemotherapy in each patient (mean plasma kisspeptin IR: prechemotherapy 1,363 \u00b1 1,076 pmol\/l vs. post-chemotherapy &lt;2 pmol\/l, P &lt; 0.0001; mean plasma hCG: prechemotherapy 227,191 \u00b1 152,354 U\/l vs. postchemotherapy 2 U\/l, P &lt; 0.0001). Plasma kisspeptin IR strongly positively correlated with plasma hCG levels ( r<jats:sup>2<\/jats:sup>= 0.99, P &lt; 0.0001). Our results suggest that measurement of plasma kisspeptin IR may be a novel tumor marker in patients with malignant GTN.<\/jats:p>","DOI":"10.1152\/ajpendo.00555.2005","type":"journal-article","created":{"date-parts":[[2006,6,7]],"date-time":"2006-06-07T01:57:37Z","timestamp":1149645457000},"page":"E878-E884","source":"Crossref","is-referenced-by-count":59,"title":["Plasma kisspeptin is raised in patients with gestational trophoblastic neoplasia and falls during treatment"],"prefix":"10.1152","volume":"291","author":[{"given":"Waljit S.","family":"Dhillo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Savage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin G.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owais B.","family":"Chaudhri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurjinder M.","family":"Nijher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa M.","family":"Foggo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garin S.","family":"Dancey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugh","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Seckl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad A.","family":"Ghatei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen R.","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"24","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.00971"},{"key":"R2","unstructured":"Clayton LA, Tyrey L, Weed JC Jr., and Hammond CB.Endocrine aspects of trophoblastic neoplasia.J Reprod Med26: 192\u2013199, 1981."},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1998.5181"},{"key":"R4","unstructured":"Cole LAand Butler S.Detection of hCG in trophoblastic disease. The USA hCG reference service experience.J Reprod Med47: 433\u2013444, 2002."},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Cole LA, Shahabi S, Butler SA, Mitchell H, Newlands ES, Behrman HR, and Verrill HL.Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases.Clin Chem47: 308\u2013315, 2001.","DOI":"10.1093\/clinchem\/47.2.308"},{"key":"R6","unstructured":"Cole LAand Sutton JM.Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer.J Reprod Med49: 545\u2013553, 2004."},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1834399100"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20357"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1468"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Esfandiari Nand Goldberg JM.Heterophile antibody blocking agent to confirm false positive serum human chorionic gonadotropin assay.Obstet Gynecol101: 1144\u20131146, 2003.","DOI":"10.1097\/00006250-200305001-00036"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.3109\/01485018508988284"},{"key":"R11A","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-7292(02)00063-2"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2003.11.066"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1210\/en.2004-0431"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021235"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-1519-02"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1159\/000083140"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021093"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1438.2000.010004330.x"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M104847200"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/88.23.1731"},{"key":"R22","unstructured":"Lee JHand Welch DR.Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1.Cancer Res57: 2384\u20132387, 1997."},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19970611)71:6<1035::AID-IJC20>3.0.CO;2-B"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.01.021"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.05.185"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409330102"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M102743200"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1210\/en.2004-0413"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1210\/en.2004-1353"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1210\/en.2004-0836"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20670"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1038\/35079135"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67143-7"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1641"},{"key":"R35","unstructured":"Qiao C, Cheng DL, Zhang SL, Wang CH, and Lin QD.[The role of KiSS-1 and matrix metalloproteinase-9 in regulation of invasion of trophoblasts].Zhonghua Yi Xue Za Zhi85: 839\u2013842, 2005."},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63854-0"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02432-6"},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035322"},{"key":"R40","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1418"},{"key":"R41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409822102"},{"key":"R42","unstructured":"Shirasaki F, Takata M, Hatta N, and Takehara K.Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3-q23.Cancer Res61: 7422\u20137425, 2001."},{"key":"R43","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-0488"},{"key":"R44","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-0323"},{"key":"R45","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-004-0629-9"},{"key":"R46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2826.2004.01240.x"},{"key":"R47","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbaexp.2004.02.005"}],"container-title":["American Journal of Physiology-Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.physiology.org\/doi\/pdf\/10.1152\/ajpendo.00555.2005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T08:32:39Z","timestamp":1586939559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.physiology.org\/doi\/10.1152\/ajpendo.00555.2005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["10.1152\/ajpendo.00555.2005"],"URL":"https:\/\/doi.org\/10.1152\/ajpendo.00555.2005","relation":{},"ISSN":["0193-1849","1522-1555"],"issn-type":[{"value":"0193-1849","type":"print"},{"value":"1522-1555","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}